Balachandran, Vinod P.
,
Łuksza, Marta
Zhao, Julia N.
Makarov, Vladimir
Moral, John Alec
Remark, Romain
Herbst, Brian
Askan, Gokce
Bhanot, Umesh
Senbabaoglu, Yasin
Wells, Daniel K.
Cary, Charles Ian Ormsby
Grbovic-Huezo, Olivera
Attiyeh, Marc
Medina, Benjamin
Zhang, Jennifer
Loo, Jennifer
Saglimbeni, Joseph
Abu-Akeel, Mohsen
Zappasodi, Roberta
Riaz, Nadeem
Smoragiewicz, Martin
Kelley, Z. Larkin
Basturk, Olca
Gönen, Mithat
Levine, Arnold J.
Allen, Peter J.
Fearon, Douglas T.
Merad, Miriam
Gnjatic, Sacha
Iacobuzio-Donahue, Christine A.
Wolchok, Jedd D.
DeMatteo, Ronald P.
Chan, Timothy A.
Greenbaum, Benjamin D.
Merghoub, Taha
Leach, Steven D.
Article History
Received: 21 November 2016
Accepted: 2 October 2017
First Online: 1 November 2017
Competing interests
: V.P.B., V.M., N.R., J.D.W. and T.A.C. have received research funding from Bristol-Myers Squibb. N.R. has received honoraria from MedImmune. D.T.F. is a co-founder of Myosotis LLC. S.G. has received research support from Immune Design, Janssen R&D, and Agenus, and serves on advisory boards for Third Rock, Ventures/Neon Therapeutics, B4CC, and Oncomed Pharmaceuticals. M.M., S.G. and R.R. are inventors of a patent regarding ‘Tissue profiling using multiplexed immunohistochemical consecutive staining’ (patent number pending). T.A.C. is a co-founder of Gritstone Oncology and is also an advisor for Genocea, Cancer Genetics, and Illumina.